If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

Share Price Information for Bushveld Minerals (BMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.57
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.57
BMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 of the Takeover Code

2 Feb 2024 14:30

RNS Number : 9141B
Bushveld Minerals Limited
02 February 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Bushveld Minerals Ltd

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mustang Energy PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

01/02/2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.1p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,880,366

 

15.46

Nill

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

1,880,366

 

15.46

Nill

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

warrants

Details, including nature of the rights concerned and relevant percentages:

636,986

exercise price: £0.30

grant date: 22/11/2023

expiry date: 15/11/2024

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

N/A

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

02/02/2024

Contact name:

Chika Edeh

Telephone number*:

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETEALAAEANLEFA
Date   Source Headline
6th Jan 20217:00 amRNSTotal Voting Rights
4th Jan 202111:34 amRNSHolding(s) in Company
18th Dec 20202:33 pmRNSPartial repayment of Duferco convertible loan note
30th Nov 20207:00 amRNSBushveld satisfies conditions of US$65m funding
27th Nov 20203:06 pmRNSGeneral meeting results
24th Nov 20207:00 amRNSQ3 and 9 months 2020 Operational Update
11th Nov 20207:00 amRNSVametco Mini-Grid Update
9th Nov 20207:01 amRNSCircular and Notice of GM
9th Nov 20207:00 amRNSSuccessful Raise of US$35M Convertible Loan Note
23rd Oct 202011:33 amRNSExchange Control Approval for Orion Transaction
19th Oct 20202:05 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20207:36 amRNSInterim Results for six months to end-June 2020
30th Sep 20207:13 amRNSFinancing with Orion and Convertible Loan Note
18th Sep 20202:37 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSVanadium Rental Partnership with Invinity
2nd Sep 20207:00 amRNSQ2 2020 and H1 2020 Operational Update
5th Aug 20203:18 pmRNSResult of AGM
3rd Aug 20207:00 amRNSInvestment in Enerox GmbH
21st Jul 202012:55 pmRNSDirector/PDMR Shareholding
30th Jun 202012:27 pmRNSPosting of accounts and notice of general meeting
23rd Jun 20208:58 amRNSFinal Results for the Year Ended 31 December 2019
14th May 202011:05 amRNSSecond Price Monitoring Extn
14th May 202011:00 amRNSPrice Monitoring Extension
11th May 20202:05 pmRNSSecond Price Monitoring Extn
11th May 20202:00 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSQ1 2020 Operational Update
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
14th Apr 202011:05 amRNSSecond Price Monitoring Extn
14th Apr 202011:00 amRNSPrice Monitoring Extension
7th Apr 202011:05 amRNSSecond Price Monitoring Extn
7th Apr 202011:00 amRNSPrice Monitoring Extension
1st Apr 20203:51 pmRNSBushveld to hold 8.71% of newly created Invinity
24th Mar 20209:12 amRNSCovid-19 Update and Operation Halt
23rd Mar 202011:05 amRNSSecond Price Monitoring Extn
23rd Mar 202011:00 amRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSDirectorate Change
12th Mar 20202:06 pmRNSSecond Price Monitoring Extn
12th Mar 20202:00 pmRNSPrice Monitoring Extension
9th Mar 20204:41 pmRNSSecond Price Monitoring Extn
9th Mar 20204:36 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSJoint Venture agreement with redT
30th Jan 20209:17 amRNSFull Year 2019 and Q4 2019 Operational Update
19th Dec 20193:02 pmRNSUpdate on investment in Enerox GmbH ("Enerox")
12th Nov 20194:32 pmRNSPotential investment in Enerox GmbH
7th Nov 20197:01 amRNSBushveld Minerals Q3 2019 Operational Update
7th Nov 20197:00 amRNSVanchem Acquisition Completed
1st Nov 20199:46 amRNSStrategy for partnering with VRFB companies
1st Nov 20199:45 amRNSSupport for redT - Avalon Merger

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.